Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
Explore this paper's citation graph
Summary
This heptavalent pneumococcal conjugate appears to be highly effective in preventing invasive disease in young children and to have a significant impact on otitis media.
- Type
- article
- Published
- 2000-03-01
- Cited by
- 2,245
- References
- 22
- OpenAlex
- https://openalex.org/W2023690749
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:72133749
Keywords
Medicine, Otitis, Immunogenicity, Pneumococcal conjugate vaccine, Serotype
References
- Ambulatory and inpatient procedures in the United States, 1996.
- Otitis media in infants and children
- Safety and Immunogenicity of Heptavalent Pneumococcal Vaccine Conjugated to CRM197 in United States Infants
- BACTERIAL POLYSACCHARIDE IMMUNE GLOBULIN (BPIG) PROTECTS INFANT RATS WITH S. PNEUMONIAE (SP) PNEUMONIA FROM BACTEREMIA, MENINGITIS AND DEATH. • 1092
- Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid.
- Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children.
- Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin.
- Book Review Healing the Masses: Cuban Health Politics at Home and Abroad By Julie M. Feinsilver. 307 pp. Berkeley, Calif., University of California Press, 1993. 45 (cloth); 17 (paper). 0-520-08218-4 (cloth)
- Diagnosis and antibiotic treatment of acute otitis media: report from International Primary Care Network.
- Otoscopy for the diagnosis of otitis media.
- Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood.
- Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers.
- Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
- Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, lot 89-S
- Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine.
- Office visits for otitis media: United States, 1975-90.
- Package.
Cited by
- Development of improved diagnostic testing methods for invasive pneumococcal disease
- Meningitis and encephalitis in children. An update.
- Could a single dose of pneumococcal conjugate vaccine in children be effective? Modeling the optimal age of vaccination.
- Epidemiology of meningitis and bacteraemia due to Streptococcus pneumoniae in The Netherlands
- Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention.
- Emerging infectious diseases in the 21st century.
- Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children.
- Dissemination of Streptococcus pneumoniae Clone Colombia5-19 in Latin America
- Comparing potential benefits of new pneumococcal vaccines with the current polysaccharide vaccine in the elderly.
- New potential in pneumococcal immunization
- Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study.
- Characterization of carbohydrate based vaccines
- Invasive meningococcal and pneumococcal disease in Switzerland: cost-utility analysis of different vaccine strategies.
- Specificity of the Antibody Response to the Pneumococcal Polysaccharide and Conjugate Vaccines in Human Immunodeficiency Virus-Infected Adults
- Differences in antibiotic prescribing patterns for children younger than five years in the three major outpatient settings.
- Estimating the transmission parameters of pneumococcal carriage in households
- PspA Protects Streptococcus pneumoniae from Killing by Apolactoferrin, and Antibody to PspA Enhances Killing of Pneumococci by Apolactoferrin
- Advances in Pneumococcal Vaccines
- Diagnosis and prevention of pneumococcal disease.
- Bacterial meningitis in children.
Related papers
- The effect of a pneumococcal conjugate vaccine on the risk of otitis media with effusion at 7 and 24 months of age.
- Immune response to pneumococcal conjugate and polysaccharide vaccines in otitis-prone and otitis-free children.
- 10-Valent pneumococcal non-typeable H. influenzae protein D conjugate vaccine (PHiD-CV10) versus 13-valent pneumococcal conjugate vaccine (PCV13) as a booster dose to broaden and strengthen protection from otitis media (PREVIX_BOOST) in Australian Aboriginal children: study protocol for a randomised
- Invasive Pneumococcal Disease in Canadian Children, 2000-2014: The Canadian Immunization Monitoring Program, Active
- Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine.
- Pneumococcal conjugate vaccine primes for antibody responses to polysaccharide pneumococcal vaccine after treatment of Hodgkin's disease.
- Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
- IMMUNE-RESPONSE TO SEROTYPE 19A FOR THE 13-VALENT PNEUMOCOCOCCAL CONJUGATE VACCINE AND THE 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN PUBLISHED HEAD-TO-HEAD RANDOMIZED CLINICAL TRIALS IN INFANTS
- DTaP hepatitis B poliovirus vaccine/Hib vaccine conjugate/pneumococcal 13 valent crm197 vaccine conjugate
- Pneumococcal Polysaccharide Conjugate Vaccine (13-Valent, Adsorbed) [Prevenar 13®]